Advances in Ultrasound Microbubble-Mediated Gene and Drug Therapy for Prostate Cancer
10.3969/j.issn.0253-9896.2014.05.030
- VernacularTitle:前列腺癌超声微泡介导药物及基因治疗研究进展
- Author:
Yun LIU
;
Yun ZHAO
;
Chaoqi LIU
;
Bing HU
- Publication Type:Journal Article
- Keywords:
prostatic neoplasms;
gene therapy;
review;
ultrasound microbubble
- From:
Tianjin Medical Journal
2014;(5):507-509
- CountryChina
- Language:Chinese
-
Abstract:
Prostate cancer is the most prevalent malignancies in elderly men. At present, gene therapy is the most po-tential treatment for late-stage prostate cancer. However, virus vector or nonvirus vector are less safety, weaker targeting function and higher immunogenic. Ultrasound microcapsular contrast agent as a drug transporter is a new type of disease tar-geted treatment strategies. It has provided a high-targeted, an effective and a safety gene therapy for prostate cancer, and brings a new hope for late-stage prostate cancer patients. This article aims to summarize the recent progress in using the mi-crobubble technology in prostate cancer.
